Methylene blue in sepsis and septic shock: a systematic review and meta-analysis
BackgroundMethylene blue is an interesting approach in reducing fluid overload and vasoactive drug administration in vasodilatory shock. The inhibition of guanylate cyclase induced by methylene blue infusion reduces nitric oxide production and improves vasoconstriction. This systematic review and me...
Main Authors: | Raquel Simões Ballarin, Taline Lazzarin, Leonardo Zornoff, Paula Schmidt Azevedo, Filipe Welson Leal Pereira, Suzana Erico Tanni, Marcos Ferreira Minicucci |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1366062/full |
Similar Items
-
Efficacy of methylene blue in refractory septic shock: study protocol for a multicenter, randomized, placebo-controlled trial
by: Jinxin Jia, et al.
Published: (2024-09-01) -
Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial
by: Miguel Ibarra-Estrada, et al.
Published: (2023-03-01) -
Methylene blue therapy in addition to standard treatment for acute-phase septic shock: a pilot randomized controlled trial
by: Fabio Luis-Silva, et al.
Published: (2024-10-01) -
Comparative study between high and low dose methylene blue infusion in septic cancer patients: a randomized, blinded, controlled study
by: Ehab Hanafy Shaker, et al.
Published: (2025-01-01) -
The use of methylene blue in adult patients with septic shock: a systematic review and meta-analysis
by: Ka Ting Ng, et al.
Published: (2025-01-01)